We study viral infections of the central nervous system (CNS) caused by herpes simplex virus type 1 and 2 (HSV-1, HSV-2), tick-borne encephalitis virus (TBEV), varicella zoster virus (VZV),) and entero- parechovirus in children and adults. We also investigate neurological complications after covid-19.
The research concept comprises inclusion of patients in long-term follow-up studies with neuroimaging, neurological and cognitive assessments to enable correlation between outcome and biochemical markers in cerebrospinal fluid and blood which may be potentially prognostic. Antiviral pharmacokinetic studies as well as treatment studies have been performed in herpes simplex encephalitis (HSE) and HSV-2 meningitis and future studies are planned.
In collaboration with the Microbiology Department we explore new diagnostic tools in viral CNS infections such as next generation sequencing (NGS). Together with the Institute of Neuroscience and Physiology we evaluate prognostic biomarkers to be used in future treatment studies. The neurological symptoms and signs in covid-19 are investigated. Specific assessments are needed for different CNS infections, and rehabilitation programs are to be evaluated to diminish neurological sequels. Finally, we study genetic predisposition in CNS herpes virus infections.
- Prognostic biomarkers and neuroimaging in relation to neurological and neuropsychological outcome in viral CNS infections
- The national burden of TBE
- The long-term sequels after HSE
- Genetic predisposition in herpes virus CNS infections
- Parecho- and enterovirus infections in neonates, children and adults
- The value of NGS diagnostics in CNS infections of unknown origin
- The impact of SARS- CoV2 (covid-19) on CNS
- Meningoencephalitis After Tick-Bite (MEATB-study)